Jazz Pharmaceuticals PLC (JAZZ) — Net Asset Quality Index
Jazz Pharmaceuticals PLC (JAZZ) has a Net Asset Quality Index of 38.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $11.86 Billion minus total liabilities of $7.33 Billion yields net assets of $4.53 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Jazz Pharmaceuticals PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jazz Pharmaceuticals PLC Net Asset Quality Index Over Time (2005–2025)
This chart shows how Jazz Pharmaceuticals PLC's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the index stands at 38.2%, representing net assets of $4.53 Billion against total assets of $11.86 Billion USD. Explore JAZZ cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Jazz Pharmaceuticals PLC (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for Jazz Pharmaceuticals PLC from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see JAZZ company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 37.0% | $4.32 Billion | $11.66 Billion | $7.34 Billion | ▲ +3.0 pp |
| 2024 | 34.1% | $4.09 Billion | $12.01 Billion | $7.92 Billion | ▲ +1.3 pp |
| 2023 | 32.8% | $3.74 Billion | $11.39 Billion | $7.66 Billion | ▲ +4.3 pp |
| 2022 | 28.5% | $3.09 Billion | $10.84 Billion | $7.75 Billion | ▼ -3.8 pp |
| 2021 | 32.2% | $3.97 Billion | $12.30 Billion | $8.33 Billion | ▼ -23.8 pp |
| 2020 | 56.0% | $3.66 Billion | $6.54 Billion | $2.88 Billion | ▼ -0.2 pp |
| 2019 | 56.2% | $3.11 Billion | $5.54 Billion | $2.43 Billion | ▲ +3.2 pp |
| 2018 | 53.0% | $2.76 Billion | $5.20 Billion | $2.45 Billion | ▲ +0.0 pp |
| 2017 | 53.0% | $2.71 Billion | $5.12 Billion | $2.41 Billion | ▲ +13.8 pp |
| 2016 | 39.1% | $1.88 Billion | $4.80 Billion | $2.92 Billion | ▼ -8.5 pp |
| 2015 | 47.6% | $1.60 Billion | $3.36 Billion | $1.76 Billion | ▲ +6.5 pp |
| 2014 | 41.1% | $1.37 Billion | $3.34 Billion | $1.97 Billion | ▼ -16.8 pp |
| 2013 | 57.9% | $1.30 Billion | $2.24 Billion | $942.69 Million | ▲ +0.9 pp |
| 2012 | 57.0% | $1.12 Billion | $1.97 Billion | $845.20 Million | ▼ -19.0 pp |
| 2011 | 76.0% | $192.79 Million | $253.57 Million | $60.78 Million | ▲ +53.5 pp |
| 2010 | 22.5% | $30.55 Million | $135.73 Million | $105.18 Million | ▲ +90.3 pp |
| 2009 | -67.8% | $-72.83 Million | $107.40 Million | $180.23 Million | ▲ +11.2 pp |
| 2008 | -79.0% | $-92.88 Million | $117.50 Million | $210.38 Million | ▼ -105.5 pp |
| 2007 | 26.5% | $54.99 Million | $207.55 Million | $152.56 Million | ▲ +108.7 pp |
| 2006 | -82.2% | $-176.30 Million | $214.57 Million | $390.87 Million | ▼ -10.4 pp |
| 2005 | -71.8% | $-118.25 Million | $164.78 Million | $283.03 Million | — |